Hypoglossal Nerve Stimulation

Low Arousal Threshold as a Predictor of Long-Term Adherence to Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea

By MedXY 09/29/2026

Low arousal threshold (ArTH) in obstructive sleep apnea patients predicts progressive disengagement from hypoglossal nerve stimulation therapy, underscoring the importance of preoperative ArTH assessment for personalized adherence strategies.

Clinical Updates news Otorhinolaryngology

Hypoglossal Nerve Stimulation and Cardiovascular Disease Risk in Obstructive Sleep Apnea: A Comprehensive Review

By MedXY 07/24/2026

This review synthesizes current evidence on the impact of hypoglossal nerve stimulation (HGNS) on cardiovascular disease incidence in obstructive sleep apnea patients, highlighting potential long-term cardiovascular benefits and mechanistic insights.

news Otorhinolaryngology Respiratory

Hypoglossal Nerve Stimulation Significantly Lowers Hypoxic Burden and Improves Sleepiness in Obstructive Sleep Apnea Patients: Insights from the STAR Trial

By MedXY 07/13/2026

Hypoglossal nerve stimulation markedly reduces hypoxic burden in obstructive sleep apnea patients, correlating with improved daytime sleepiness independent of AHI changes, suggesting hypoxic burden as a complementary treatment outcome metric.

Neurology news Respiratory

Proximal Hypoglossal Nerve Stimulation Shows Promise for Moderate-to-Severe OSA in Landmark OSPREY Trial

By MedXY 04/24/2026

A recent randomized controlled trial demonstrates that proximal hypoglossal nerve stimulation significantly improves obstructive sleep apnea symptoms in patients intolerant to positive airway pressure therapy.